{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T04:28:07Z","timestamp":1775708887082,"version":"3.50.1"},"reference-count":25,"publisher":"Informa UK Limited","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CMAR"],"DOI":"10.2147\/cmar.s316561","type":"journal-article","created":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:47:57Z","timestamp":1626050877000},"page":"5613-5621","source":"Crossref","is-referenced-by-count":10,"title":["Efficacy of Venetoclax Combined with Decitabine-Based Treatment for Heavily Pre-Treated Relapsed or Refractory AML Patients in a Real-World Setting"],"prefix":"10.2147","volume":"Volume 13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1567-3625","authenticated-orcid":true,"given":"Juan","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Na","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xing","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wen","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3668-3558","authenticated-orcid":true,"given":"Li","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huilan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangquan","family":"Geng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zimin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Changcheng","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","published-online":{"date-parts":[[2021,7]]},"reference":[{"key":"ref1","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1016\/S1470-2045(17)30416-3","volume":"18","author":"Perl","year":"2017","journal-title":"Lancet Oncol"},{"key":"ref2","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/s41375-018-0148-3","volume":"32","author":"Burnett","year":"2018","journal-title":"Leukemia"},{"key":"ref3","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1002\/ajh.25000","volume":"93","author":"DiNardo","year":"2018","journal-title":"Am J Hematol"},{"key":"ref4","first-page":"794","volume":"2","author":"Shahswar","year":"2018","journal-title":"HemaSphere"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1182\/blood-2016-08-733196","volume":"129","author":"Hallek","year":"2017","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1513257","volume":"374","author":"Roberts","year":"2016","journal-title":"N Engl J Med"},{"key":"ref7","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1038\/nm.3788","volume":"21","author":"Chan","year":"2015","journal-title":"Nat Med"},{"key":"ref8","doi-asserted-by":"publisher","first-page":"1106","DOI":"10.1158\/2159-8290.CD-16-0313","volume":"6","author":"Konopleva","year":"2016","journal-title":"Cancer Discov"},{"key":"ref9","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/S1470-2045(18)30010-X","volume":"19","author":"DiNardo","year":"2018","journal-title":"Lancet Oncol"},{"key":"ref10","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1182\/blood-2018-08-868752","volume":"133","author":"DiNardo","year":"2019","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","first-page":"2659","DOI":"10.3324\/haematol.2019.242826","volume":"105","author":"Bewersdorf","year":"2020","journal-title":"Haematologica"},{"key":"ref12","first-page":"1353","volume":"130","author":"Goldberg","year":"2017","journal-title":"Blood"},{"key":"ref13","doi-asserted-by":"publisher","first-page":"e404","DOI":"10.3324\/haematol.2018.188094","volume":"103","author":"Aldoss","year":"2018","journal-title":"Haematologica"},{"key":"ref14","doi-asserted-by":"publisher","first-page":"1927","DOI":"10.1007\/s00277-019-03719-6","volume":"98","author":"Ram","year":"2019","journal-title":"Ann Hematol"},{"key":"ref15","doi-asserted-by":"publisher","first-page":"E253","DOI":"10.1002\/ajh.25567","volume":"94","author":"Aldoss","year":"2019","journal-title":"Am J Hematol"},{"key":"ref16","doi-asserted-by":"crossref","unstructured":"DiNardo CD, Maiti A, Rausch CR, et al. 10-day decitabine with venetoclax for newly diagnosed intensive chemotherapy ineligible, and relapsed or refractory acute myeloid leukaemia: a single-centre, Phase 2 trial. Lancet Haematol. 2020;7(10):e724\u2013e736. doi:10.1016\/S2352-3026(20)30210-6","DOI":"10.1016\/S2352-3026(20)30210-6"},{"key":"ref17","doi-asserted-by":"publisher","first-page":"501","DOI":"10.1007\/s00277-020-03911-z","volume":"99","author":"Wang","year":"2020","journal-title":"Ann Hematol"},{"key":"ref18","doi-asserted-by":"publisher","first-page":"106317","DOI":"10.1016\/j.leukres.2020.106317","volume":"91","author":"Lou","year":"2020","journal-title":"Leuk Res"},{"key":"ref19","doi-asserted-by":"publisher","first-page":"1511","DOI":"10.1002\/ajh.25978","volume":"95","author":"Morsia","year":"2020","journal-title":"Am J Hematol"},{"key":"ref20","doi-asserted-by":"publisher","first-page":"106314","DOI":"10.1016\/j.leukres.2020.106314","volume":"90","author":"Gaut","year":"2020","journal-title":"Leuk Res"},{"key":"ref21","doi-asserted-by":"publisher","first-page":"2221","DOI":"10.1080\/10428194.2020.1761964","volume":"61","author":"Ganzel","year":"2020","journal-title":"Leuk Lymphoma"},{"key":"ref22","first-page":"244020","author":"Mali","year":"2019","journal-title":"haematol"},{"key":"ref23","doi-asserted-by":"publisher","first-page":"528","DOI":"10.5306\/wjco.v11.i8.528","volume":"11","author":"Wilde","year":"2020","journal-title":"World J Clin Oncol"},{"key":"ref24","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1111\/bjh.16271","volume":"188","author":"Eyre","year":"2020","journal-title":"Br J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1056\/NEJMoa2012971","volume":"383","author":"DiNardo","year":"2020","journal-title":"N Engl J Med"}],"container-title":["Cancer Management and Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71593","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.dovepress.com\/getfile.php?fileID=71593","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,7,12]],"date-time":"2021-07-12T00:48:04Z","timestamp":1626050884000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.dovepress.com\/efficacy-of-venetoclax-combined-with-decitabine-based-treatment-for-he-peer-reviewed-fulltext-article-CMAR"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":25,"URL":"https:\/\/doi.org\/10.2147\/cmar.s316561","relation":{},"ISSN":["1179-1322"],"issn-type":[{"value":"1179-1322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7]]}}}